Increasing immunology and immuno-oncology research would upsurge the growth of Flow cytometry Market. North America to witness the highest growth

Global Flow Cytometry Market is expected to expand at a significant CAGR during the forecast period (2021-2027). The increasing prevalence of chronic diseases such as Cancer, HIV, and the growing acceptance of recombinant DNA technology for antibody production has stimulated the demand for flow cytometry across the world. The field of flow cytometry has rapidly grown worldwide due to the growing research in the field of Covid-19 and the growing adoption of clinical trials. The enhanced technological advancements in flow cytometers would further upsurge the growth of the flow cytometry market during the forecast period.

Factors driving the flow cytometry market include the growing acceptance of flow cytometry techniques in research activities and clinical trials across the world and high incidence and prevalence of HIV and cancer. Furthermore, technological advancements in the field of flow cytometers is also anticipated to drive the market. For instance, in March 2019, Becton, Dickinson and Company, announced the CE-IVD certification for the BD FACSDuet (TM) automated flow cytometry system. This fully automated instrument enables clinical laboratories to improve their efficiency by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric (TM) clinical flow cytometer.

For a detailed analysis of the Global Flow Cytometry Market browse through -

The flow cytometry market has observed a drastic expansion during the COVID-19 pandemic. Globally, Covid-19 related research have headed to an increased dependency on flow cytometry techniques for the study of specific Covid-19 virus. For instance, in August 2020, Two trials have been conducted by the Corona Virus Prevention Network (CoVPN) on monoclonal antibodies for their ability to prevent Covid-19 in uninfected adults who were at high risk of acquiring SARS-CoV-2 due to living or working with infected individuals. One trial would test REGN-COV-2, a monoclonal combination supplied by Regeneron Pharmaceuticals, and a second trial will test a monoclonal antibody (LY-CoV555) made by Eli Lilly and Company. Further, increasing implementation of flow cytometry techniques in research activities and clinical trials has provided a wide range of growth opportunities for market players. In 2020, Cytek Biosciences Inc., encouraged researchers and clinicians worldwide, studying the impact of the Covid-19 virus on human immune systems. The Cytek Biosciences completely endorsed researchers during this crucial period by providing technical assistance by their flow cytometers, Cytek Aurora, Cytek Athena, and Cytek Northern Lights systems.

Based on product, the market is bifurcated into instruments, reagents & consumables, replaceable components, accessories, software, and services. The reagents & consumables segment grabbed the major market in 2020 due to their augmented implementations in diagnostic and research fields. Moreover, the overview of multiplex probes and reagents for precise applications in diagnostics as well as drug discovery is anticipated to increase the growth opportunities of this segment in research laboratories and small peripheral laboratories. Based on technology, the market is bifurcated into cell-based and bead-based technologies. The bead-based segment ruled the market and accounted for the maximum share in 2020 due to the practical advantages presented by this technology over the cell-based technology (such as ELISA, northern blot, and western blot), comprising its ability to spot multiple analytes, high reproducibility, stability, and speed.

For a detailed analysis of the Covid-19 Impact on the Flow Cytometry Market browse through -

Based on application, the market is bifurcated into research applications, clinical applications, and industrial applications. The research applications segment grabbed the major market in 2020. The highest share of the segment can be attributed to the increasing R&D activities connected to cancer and infectious diseases, including Covid-19. Furthermore, increasing R&D investments in the pharmaceutical and biotechnology companies are also anticipated to generate a favorable atmosphere for the market growth. Based on end-user, the market is bifurcated into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. The hospitals & clinical testing laboratories segment dominated the market in 2020.

Additionally, the report provides detailed analyusis for major regions including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America dominated the market in 2020, owing to the high government funding, robust personal healthcare spending, developed awareness programs, rapid acceptance of new analytical techniques, and the presence of skilled workforces. Some of the major players operating in the market include Thermo Fisher Scientific, Beckman Coulter, Inc., Danaher Corporation, Becton, Dickinson and Company, Luminex Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Apogee Flow Systems Ltd., Sony Biotechnology, Inc., etc.

Request for Sample of the report browse through -

Global Flow Cytometry Market Segmentation

Market Insight, by Product

  • Instruments
  • Reagents and Consumables
  • Replaceable components
  • Accessories
  • Software
  • Services

Market Insight, by Technology

  • Cell-based
  • Bead-based

Market Insight, by Application

  • Research Applications
  • Clinical Applications
  • Industrial Applications

Market Insight, by End-user

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

Market Insight, by Region

  • North America Flow Cytometry Market
    • United States
    • Canada
    • Rest of North America
  • Europe Flow Cytometry Market
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific Flow Cytometry Market
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of World Flow Cytometry Market

Top Company Profiles

  • Thermo Fisher Scientific
  • Beckman Coulter, Inc.
  • Danaher Corporation
  • Becton, Dickinson, and Company
  • Luminex Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec
  • Apogee Flow Systems Ltd.
  • Sony Biotechnology, Inc.